about
Cannabinoid-hypocretin cross-talk in the central nervous system: what we know so farMetabolic signals in sleep regulation: recent insightsNeural plasticity in hypocretin neurons: the basis of hypocretinergic regulation of physiological and behavioral functions in animalsThe hypocretins/orexins: integrators of multiple physiological functionsOrexin antagonists for neuropsychiatric disease: progress and potential pitfallsLesions of the paraventricular nucleus of the thalamus differentially affect sign- and goal-tracking conditioned responses.Entry-into-humans study with ACT-462206, a novel dual orexin receptor antagonist, comparing its pharmacodynamics with almorexantOrexinergic input to dopaminergic neurons of the human ventral tegmental areaDifferential sleep-promoting effects of dual orexin receptor antagonists and GABAA receptor modulatorsIntravenous prenatal nicotine exposure increases orexin expression in the lateral hypothalamus and orexin innervation of the ventral tegmental area in adult male rats.It's MORe exciting than mu: crosstalk between mu opioid receptors and glutamatergic transmission in the mesolimbic dopamine system.Considerations about rodent models of binge eating episodes.Repeated episodes of heroin cause enduring alterations of circadian activity in protracted abstinence.The contribution of brain reward circuits to the obesity epidemicThe neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders.Sleep disorders, obesity, and aging: the role of orexinNeuroanatomical circuitry mediating the sensory impact of nicotine in the central nervous systemOrexin/hypocretin role in reward: implications for opioid and other addictionsMotivational activation: a unifying hypothesis of orexin/hypocretin functionHypocretin receptor 2 antagonism dose-dependently reduces escalated heroin self-administration in rats.Binge-like consumption of ethanol and other salient reinforcers is blocked by orexin-1 receptor inhibition and leads to a reduction of hypothalamic orexin immunoreactivity.Effect of 1-substitution on tetrahydroisoquinolines as selective antagonists for the orexin-1 receptorOrexin-1 receptor signaling increases motivation for cocaine-associated cuesDifferential roles of medial prefrontal subregions in the regulation of drug seeking.Modulation of Food Reward by Endocrine and Environmental Factors: Update and Perspective.CDH13 and HCRTR2 May Be Associated with Hypersomnia Symptom of Bipolar Depression: A Genome-Wide Functional Enrichment Pathway AnalysisAcetylcholine Acts through Nicotinic Receptors to Enhance the Firing Rate of a Subset of Hypocretin Neurons in the Mouse Hypothalamus through Distinct Presynaptic and Postsynaptic Mechanisms(.)The importance of the 6- and 7-positions of tetrahydroisoquinolines as selective antagonists for the orexin 1 receptor.Orexin A-induced enhancement of attentional processing in rats: role of basal forebrain neuronsThe highly selective orexin/hypocretin 1 receptor antagonist GSK1059865 potently reduces ethanol drinking in ethanol dependent mice.Genes and primary headaches: discovering new potential therapeutic targets.An orexin hotspot in ventral pallidum amplifies hedonic 'liking' for sweetnessA role for hypocretin/orexin receptor-1 in cue-induced reinstatement of nicotine-seeking behaviorOrexins contribute to restraint stress-induced cocaine relapse by endocannabinoid-mediated disinhibition of dopaminergic neurons.Nucleus Accumbens Shell and mPFC but Not Insula Orexin-1 Receptors Promote Excessive Alcohol Drinking.An investigation of interactions between hypocretin/orexin signaling and glutamate receptor surface expression in the rat nucleus accumbens under basal conditions and after cocaine exposure.Acute high fat diet consumption activates the mesolimbic circuit and requires orexin signaling in a mouse model.Orexin 1 receptor antagonists in compulsive behavior and anxiety: possible therapeutic use.Orexin-1 and orexin-2 receptor antagonists reduce ethanol self-administration in high-drinking rodent modelsThe paraventricular nucleus of the thalamus is recruited by both natural rewards and drugs of abuse: recent evidence of a pivotal role for orexin/hypocretin signaling in this thalamic nucleus in drug-seeking behavior.
P2860
Q21090468-2C9EDE46-51EB-4EBC-A895-FA515ECA5A19Q26770483-7563175A-00BE-45E7-A9C0-9930BDB9108FQ26779699-78B1D944-FFD2-498B-B59D-DF8C909DAC8CQ26830704-1DFCF0A9-971A-4260-AD03-5FE8AD00197AQ26852653-00A33D99-2E56-4F7E-B214-9F426F1CE13FQ27312768-7092160E-9A5F-48FE-A3D2-C9A844398CFAQ28237266-65436003-EDF7-4026-80E5-9C4CBD6DB150Q28537849-C2BEA15F-2DC7-4058-9C4C-C10C23430033Q30423240-69FEAC9C-B4F6-4E91-A95E-935D2EBBC680Q30429611-30F7C2B1-D179-415A-976F-E433E5639AB4Q30437184-20E118DA-B571-497D-AFF1-923EA8E72D9BQ33569309-533D362B-D1F0-4DD5-8FF8-D585E703AE84Q33771947-7AC5C578-85C6-4193-8FCC-97155E545D9DQ34317475-6AFB3167-B544-4B5A-A4E7-A5604A2256ACQ34363257-B919F4BF-6CA4-4C40-A80F-1CC5F8555AB4Q34451399-73A19BAC-FC44-437B-85D6-A1432E9270B5Q34734457-0E8B1CA3-08D6-4246-907A-43922C4FCAC7Q34939568-BCFA965F-7DB0-4778-87C9-10ABBE2B0EF2Q35105241-56022874-003A-4D28-8ACB-688623C9FD79Q35199989-B2DE17CB-62F4-4720-8CDB-943C29F504C6Q35295721-73EF9079-8BA0-427A-B90D-EECDE661BF6AQ35450376-E6591B68-02DE-4BE1-AC41-2378A16C7624Q35572211-B18496A8-D4BA-4F50-8B9F-E562431F11F4Q35756569-D2909FA4-A847-46CE-9507-756C7EAF262DQ35850462-C2E1C924-9A73-4349-8B7D-45548D0DCA8FQ35859127-6B34B457-2FCB-4681-917C-87283EAEA2A7Q36001330-8749737D-20F9-42EB-AA11-C1EEFAC72C50Q36011454-C88BEB05-903F-4816-9584-999DC02CDC92Q36510474-4ADD9967-8234-4C6A-9ECD-994EB124FCBCQ36731312-79FC5ED1-58BA-4994-8599-E6CC5170D141Q37027988-44AFC7F1-6555-4A5F-943E-E0F640639112Q37030166-EC465871-AECA-4E84-A864-160F5FAE95D2Q37030201-BBA9FCCE-0BFA-45B6-A230-33F33632D57DQ37128023-5FD346DB-B24D-4EFD-896D-BC28314866CFQ37215453-5F59ABA3-646D-4378-93AC-F85F8B9D551EQ37406154-C42DE8DF-0133-4859-AC0D-27C166440344Q37510771-6D6008D5-9B9E-4566-AA45-546119B483E0Q37581553-3B4DF20A-6E76-4F1B-8F14-F46DE1B26731Q37601680-F3349EE3-742A-49DA-B57A-114764546030Q37695281-68314FBC-34E4-471D-B8C8-37818EAB901D
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Multiple roles for orexin/hypocretin in addiction
@ast
Multiple roles for orexin/hypocretin in addiction
@en
Multiple roles for orexin/hypocretin in addiction
@nl
type
label
Multiple roles for orexin/hypocretin in addiction
@ast
Multiple roles for orexin/hypocretin in addiction
@en
Multiple roles for orexin/hypocretin in addiction
@nl
prefLabel
Multiple roles for orexin/hypocretin in addiction
@ast
Multiple roles for orexin/hypocretin in addiction
@en
Multiple roles for orexin/hypocretin in addiction
@nl
P2093
P2860
P3181
P1476
Multiple roles for orexin/hypocretin in addiction
@en
P2093
David E. Moorman
Gary Aston-Jones
Gregory C. Sartor
Rachel J. Smith
Stephen V. Mahler
P2860
P304
P3181
P356
10.1016/B978-0-444-59489-1.00007-0
P407
P577
2012-01-01T00:00:00Z